E613-1343 Screening compound: N-[3-(3-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methoxy}acetamide

E613-1343 Screening compound: N-[3-(3-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methoxy}acetamide
E613-1343 Screening compound: N-[3-(3-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methoxy}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E613-1343
N-[3-(3-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methoxy}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E613-1343

Molecular Formula

C19H14ClN3O5 (C19 H14 ClN3 O5)

Compound Name

N-[3-(3-chlorophenyl)-1,2-oxazol-5-yl]-2-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methoxy}acetamide

IUPAC name

N-[3-(3-chlorophenyl)-12-oxazol-5-yl]-2-{[5-(furan-2-yl)-12-oxazol-3-yl]methoxy}acetamide

SMILES

O=C(COCc1noc(-c2ccco2)c1)Nc1cc(-c2cccc(Cl)c2)no1

InChI

InChI=1S/C19H14ClN3O5/c20-13-4-1-3-12(7-13)15-9-19(28-23-15)21-18(24)11-25-10-14-8-17(27-22-14)16-5-2-6-26-16/h1-9H,10-11H2,(H,21,24)

InChI Key

CQZODKNVJVVFGJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09784317

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.79

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.808

Distribution Coefficient, logD

3.808

Water Solubility, LogSw

-4.34

Polar Surface Area

84.440

Acid Dissociation Constant (pKa)

10.40

Base Dissociation Constant (pKb)

-2.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.50

E613-1343 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

GPCR Targeted Library (31838 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
  • Ion Channels
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E613-1343 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E613-1343?
Check Price and Availability of E613-1343, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E613-1343 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E613-1343
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E613-1343
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E613-1343 available by request